Congratulations to Tori Czech, Pharm.D. (’16), and Ph.D. candidate in the Integrative Pharmaceutical Medicine (IPM) Graduate Program, for being awarded NEOMED’s 2018 Integrated Pharmaceutical Medicine Graduate Research Grant.
“I was inspired to pursue a Ph.D., in addition to my Pharm.D., because I have always wanted to be a researcher. And while there are many job opportunities for people with Pharm.D.s in the research field, there are even more options for people who hold both degrees,” says Czech.
Czech will use the IPM grant to continue her dissertation research in the lab of Moses Oyewumi, Ph.D., an associate professor of pharmaceutical sciences who focuses on the bioengineering of drug delivery systems. “Tori’s research is on development of innovative delivery strategies that we can apply to drugs that can accelerate bone regeneration. We have used this strategy for repurposing drugs that can be applied in fracture healing,’’ explains Dr. Oyewumi.
A research collaboration
Dr. Oyewumi’s lab is collaborating with the lab of Fayez Safadi, Ph.D., professor of anatomy and neurobiology, to investigate how the delivery systems could be applied in the case of Osteoactivin— a protein naturally occurring in the body, which Dr. Safadi’s research has shown to be effective in bone regeneration.
For more information about the graduate research grant, please contact Denise Inman, assistant professor of pharmaceutical sciences and IPM program director, at dinman@neomed.edu.